✦ LIBER ✦

First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non-Small-Cell Lung Cancer: The TORCH Randomized Trial

✍ Scribed by Gridelli, C.; Ciardiello, F.; Gallo, C.; Feld, R.; Butts, C.; Gebbia, V.; Maione, P.; Morgillo, F.; Genestreti, G.; Favaretto, A.; Leighl, N.; Wierzbicki, R.; Cinieri, S.; Alam, Y.; Siena, S.; Tortora, G.; Felletti, R.; Riccardi, F.; Mancuso, G.; Rossi, A.; Cantile, F.; Tsao, M.-S.; Saieg, M.; da Cunha Santos, G.; Piccirillo, M. C.; Di Maio, M.; Morabito, A.; Perrone, F.

Book ID: 115538202
Publisher: American Society of Clinical Oncology
Year: 2012
Tongue: English
Weight: 259 KB
Volume: 30
Category: Article
ISSN: 0732-183X
DOI: 10.1200/jco.2011.41.2056

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An International, Multicenter, Randomize

An International, Multicenter, Randomized Phase III Study of First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Versus First-Line Cisplatin/Gemcitabine Followed by Second-Line Erlotinib in Advanced Non–Small-Cell Lung Cancer: Treatment Rationale and Protocol Dynamics of the TORCH Trial

✍ Cesare Gridelli; Charles Butts; Fortunato Ciardiello; Ronald Feld; Ciro Gallo; F 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 91 KB

Cisplatin and gemcitabine first-line che

Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: A phase III trial

✍ Brodowicz, Thomas; Krzakowski, Maciej; Zwitter, Matjaz; Tzekova, Valentina; Raml 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 237 KB

Nimotuzumab combined with gemcitabine an

Nimotuzumab combined with gemcitabine and cisplatin as second-line chemotherapy for advanced non-small-cell lung cancer

✍ Hua-qing Wang; Yangang Ren; Zheng-zi Qian; Kai Fu; Hui-lai Zhang; Wei Li; Yun Ho 📂 Article 📅 2012 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 149 KB

First-line gemcitabine with cisplatin or

First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: a phase III trial

✍ Wachters, F M; van Putten, J W G; Kramer, H; Erjavec, Z; Eppinga, P; Strijbos, J 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 133 KB

Randomized, Phase III Study of Gemcitabi

Randomized, Phase III Study of Gemcitabine or Erlotinib Maintenance Therapy Versus Observation, With Predefined Second-Line Treatment, After Cisplatin-Gemcitabine Induction Chemotherapy in Advanced Non-Small-Cell Lung Cancer

✍ Perol, M.; Chouaid, C.; Perol, D.; Barlesi, F.; Gervais, R.; Westeel, V.; Crequi 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 264 KB

Gemcitabine and vinorelbine as first-lin

Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer: a phase II trial

✍ E Laack; T Mende; J Benk; A Chemaissani; J Scholtze; C Lorenz; A Niestroy; K Dal 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 144 KB